Latest News and Press Releases

Octopus AIM VCT 2 plc Net Asset Value Octopus AIM VCT 2 plc announces that as at 1 December 2025 the unaudited net asset value of the Ordinary shares was approximately 36.8 pence per share. For...

Octopus AIM VCT plc Net Asset Value Octopus AIM VCT plc announces that as at 1 December 2025 the unaudited net asset value of the Ordinary shares was approximately 48.7 pence per share. For further...

BHUBANESWAR, India, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cleus, an emerging uncensored artificial intelligence platform, today announced the release of its latest image generation model, marking the...

DUBAI, United Arab Emirates, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a new crypto project building a decentralized lending protocol, has released an update confirming continued...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

L’avion Bombardier Global6000 modifié pour la mission aéroportée SIGINT PEGASUS est en phase d’essais en vol avant son transfert en Allemagne. Photo : Bombardier Défense HAMBOURG, Allemagne, 11...

Stay tax-ready with RentRedi’s new Accounting Suite: AI receipt capture, organized expenses, clear P&Ls, and Schedule E summaries in one app.

The modified Bombardier Global 6000 for the PEGASUS airborne SIGINT mission undergoing flight trials ahead of transfer to Germany. Photo: Bombardier Defense HAMBURG, Germany, Dec. 11, 2025 (GLOBE...

In the registrational clinical trial, zurletrectinib demonstrated outstanding efficacy and a favorable safety profile, with ORR of 89.1% and DCR of 96.4%.

Tokenising over 46 million domains on Solana. D3 and InterNetX bring Web2 infrastructure onchain with Doma Protocol, unlocking a new RWA asset class